WallStreetZenWallStreetZen

NASDAQ: INAB
In8bio Inc Stock Ownership - Who owns In8bio?

Insider buying vs selling

Have In8bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jeremy R. GraffDirector2023-09-132,500$0.95
$2.38kBuy
Patrick McCallChief Financial Officer2023-08-251,000$1.03
$1.03kBuy
William Taiwei HoPresident and CEO2023-08-2423,800$1.05
$24.99kBuy

1 of 1

INAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INAB insiders and whales buy or sell their stock.

INAB Shareholders

What type of owners hold In8bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher22.17%9,597,434$10.08MInsider
Leslie W. Kreis22.17%9,597,434$10.08MInsider
Aigh Capital Management LLC9.47%4,098,361$4.30MInstitution
William Taiwei Ho5.85%2,531,012$2.66MInsider
Ensign Peak Advisors Inc2.58%1,118,266$1.17MInstitution
Alyeska Investment Group LP1.89%819,672$860.66kInstitution
683 Capital Management LLC1.42%614,754$645.49kInstitution
Vanguard Group Inc0.96%416,696$437.53kInstitution
Peter C. Brandt0.85%369,730$388.22kInsider
Voss Capital LLC0.79%341,209$358.27kInstitution

1 of 3

INAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INAB19.83%52.04%Net Buying
NXTC47.82%50.20%
CLNN9.06%52.75%Net BuyingNet Selling
AADI26.99%73.01%Net SellingNet Selling
QNCX15.43%84.57%Net Buying

In8bio Stock Ownership FAQ

Who owns In8bio?

In8bio (NASDAQ: INAB) is owned by 19.83% institutional shareholders, 52.04% In8bio insiders, and 28.13% retail investors. Aaron Gl Fletcher is the largest individual In8bio shareholder, owning 9.60M shares representing 22.17% of the company. Aaron Gl Fletcher's In8bio shares are currently valued at $9.89M.

If you're new to stock investing, here's how to buy In8bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.